Forxiga 10 mg film-coated tablets clinical trials
4 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Evolution of proteinuria in renal transplant patients treated with Dapagliflozin for nephroprotection. DAPAGREFFE
This study is looking at how a medicine called Dapagliflozin (also known as Forxiga) affects kidney health in people who have had a kidney transplant. Researchers want to see if it can help protect their new kidney by reducing a certain protein in their urine.
For: chronic renal failureFrance - Ongoing, recruitingTherapeutic use (Phase IV)
proMoting Effective Renoprotection in Cardiac sURgery patients by Inhibition of SGLT-2
This study is looking at whether a medicine called Forxiga can help protect kidneys in people having heart surgery. It wants to see if Forxiga can reduce the chances of kidney problems happening after the operation.
For: AKINetherlands - AuthorisedTherapeutic use (Phase IV)
Effects of sodium-glucose cotransporter 2 inhibition on the mechanisms of heart failure with preserved ejection fraction
This study is looking at how a common heart failure medicine called Forxiga works in people who have a specific type of heart failure. It aims to understand the drug's effects on the heart's pumping ability and structure, helping us learn more about how it helps patients.
For: Heart failure with preserved ejection fractionSpain - AuthorisedTherapeutic use (Phase IV)
Early use of dapagliflozin in patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 Dapagliflozin trial
This study is looking at whether a drug called Forxiga can help people who have recently had a heart attack. Researchers will check if it can reduce damage to the heart muscle and improve overall health after three months.
For: Acute Myocardial InfarctionItaly